Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
CA 2511178 A1 · Owner: Ahlijanian, Michael K. · Inventors: Tang, Xiao-Qing; Liras, Spiros J.; Ghosh, Soumitra S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds which have utility in the treatment of conditions associated with altered mitochondrial function. The compounds having structure (I) including , stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof wherein R1, R2, R3, R4, R5 and R6 are as defined herein. Pharmaceutical compositions containing a compound of structure (I) as well as methods , relating to the use thereof are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 19, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 19, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.